• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Cara Therapeutics Inc

+ Add to Watchlist

CARA:US

13.6900 USD 0.1700 1.26%

As of 11:35:44 ET on 07/29/2014.

Snapshot for Cara Therapeutics Inc (CARA)

Open: 13.5200 Day's Range: 13.5000 - 13.6900 Volume: 5,227
Previous Close: 13.5200 52wk Range: 10.4000 - 23.2500 1-Yr Rtn: -

Stock Chart for CARA

No chart data available.
  • CARA:US 13.6200
  • 1D
  • 1M
  • 1Y
13.5200
Interactive CARA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CARA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.9870
Est. PEG Ratio -
Market Cap (M USD) 305.58
Shares Outstanding (M) 22.60
30 Day Average Volume 88,865
Price/Book (mrq) 1.1946
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/11/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CARA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CARA

Cara Therapeutics Inc. develops therapeutics. The Company produces novel drugs for the treatment of human diseases associated with pain and inflammation. Cara Therapeutics serves the healthcare industry in the United States.

Derek ChalmersPresident/CEO/Co-FounderJosef C SchoellChief Financial Officer
Robert A MedveChief Medical OfficerFrederique MenzaghiVP:R&D/Co-Founder
More Company Profile & Key Executives for CARA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil